— Know what they know.
Not Investment Advice

IMMG OTC

Immage Biotherapeutics Corp.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0%
$0.00
+0.00 (+0.00%)
 
OTC · Financial Services · Financial - Conglomerates · Tech Score Neutral · Power 46 · $15174 mcap · 46M float · 0.0020% daily turnover

Cash Flow Trends

Operating Cash Flow
-$216K -377757.7% ▼
Capital Expenditures
$0 +100.0% ▲
Free Cash Flow
-$216K -211688.5% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$164K +7004241.8% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2012FY2013FY2014FY2015FY2016
— Operating Activities —
Net Income-$8-$12-$19K-$59-$216K
Depreciation & Amort.$0$0$0$1$9K
Stock-Based Comp.$0$0$0$0$0
Change in Working Capital$0$150$941-$1-$8K
Other Non-Cash Items$3-$150$0$2$0
Operating Cash Flow-$5-$12-$18K-$57-$216K
— Investing Activities —
Capital Expenditures$0$0$0-$45$0
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$0$0$0$0
Investing Cash Flow$0$0$0-$45$0
— Financing Activities —
Net Debt Issuance$0$0$0$0$11K
Stock Repurchased$0$0-$10$0$0
Dividends Paid$0$0$0$0$0
Other Financing$25$14K$7K$135-$6K
Financing Cash Flow$25$14K$13K$135$380K
Net Change in Cash$20$2K-$5K-$2$164K
Cash End of Period$20$7K$2K$0$197K
Free Cash Flow-$5-$12K-$18K-$102-$216K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms